Download Our DHN Survey Result 2024
scalehealthtech Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

TruDoc Healthcare Acquires Mumbai’s Wellthy Therapeutics for India Expansion

Written by : Jayati Dubey

February 15, 2024

Category Img

This collaboration aims to provide round-the-clock access to high-quality care, personalized treatment plans, and innovative care delivery methods.

TruDoc Healthcare, a virtual primary care provider in the GCC, has acquired Wellthy Therapeutics, a Mumbai-based clinically validated chronic disease management platform.

This strategic move is aimed at redefining healthcare outcomes, quality, and patient experience in the region while signaling TruDoc's expansion into new markets, including India.

The acquisition brings together Wellthy Therapeutics' behavioral science and digital therapeutic solutions with TruDoc's extensive virtual and in-home healthcare services.

This collaboration aims to provide round-the-clock access to high-quality care, personalized treatment plans, and innovative care delivery methods. The synergies between the two entities hold the promise of significantly improving health outcomes and optimizing healthcare expenditures.

Talking about this acquisition, Vish Narain, chairman of TruDoc, said, "With this acquisition, we're hitting a key milestone on our path to transforming healthcare across the GCC and beyond. We are crafting an integrated care experience that's tailored to the changing needs of our patients and our clients. We envision a future where primary care is easily accessible, starting with digital platforms, followed by in-home care, with in-clinic visits only when needed."

Patient-Centric Integrated Care

At the core of this alliance is a commitment to patient-centric care aimed at offering a seamless and integrated healthcare experience. By leveraging TruDoc's leadership in the GCC and Wellthy's proven track record in Asia, the partnership seeks to strengthen TruDoc's position as a technology-enabled primary care provider in the region.

Sharing excitement on the acquisition, Abhishek Shah, founder of Wellthy Therapeutics, said, "Our founding goal at Wellthy was ambitious: to impact millions of lives. This partnership accelerates our progress toward our impact goal, broadening our reach while enhancing patient outcomes. The combined capabilities are uniquely positioned to significantly lower healthcare expenses, contribute to savings, and reduce unnecessary hospital and clinic visits, while substantially improving the patient experience."

The synergy between TruDoc and Wellthy Therapeutics is expected to help insurers, employers, and governments to provide high-quality, individualized care.

The integrated services include connected care, remote monitoring, and instant access to healthcare professionals, all supported by artificial intelligence (AI) and personalized care protocols. This approach promises to not only elevate patient care but also deliver validated results in terms of cost reductions across the outpatient care spectrum.

Vision 2025: Impacting 10 Million Lives

In alignment with Vision 2025, TruDoc and Wellthy Therapeutics are aligning their clinical strengths and digital health expertise to create a sustainable healthcare ecosystem aimed at impacting 10 million lives.

This strategic partnership promises a significant step towards closing the loop on full-stack primary care, leveraging TruDoc's clinical proficiency and Wellthy Therapeutics' offering in digital health and behavioral science.

The integrated care model, combining virtual and in-home healthcare services with cutting-edge digital therapeutic solutions, is aimed at positioning the partnership at the forefront of healthcare innovation.

The integration of digital health solutions with comprehensive primary care services holds the potential to drive positive healthcare outcomes, marking a paradigm shift in how healthcare is delivered and experienced in the region.

In another development in the digital health space, in December last year, global pharmaceutical giant Cipla invested an additional INR 42 Cr ($5.04 million) in Mumbai-based healthtech startup GoApptiv.

The startup offers comprehensive business solutions encompassing distribution, digital solutions, integrated brand sales management, digital marketing, patient support, and healthcare data analytics. Cipla's investment aligns with its goal of expanding into rural and underserved areas, addressing healthcare gaps through innovative digital solutions.


Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.


© Digital Health News 2024